BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17417760)

  • 1. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
    Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.
    Feng B; Eknoyan G; Guo ZS; Jadoul M; Rao HY; Zhang W; Wei L
    Nephrol Dial Transplant; 2012 Feb; 27(2):640-6. PubMed ID: 21558431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.
    Fabrizi F; Fogazzi GB; Cresseri D; Passerini P; Martin P; Donato MF; Rumi MG; Messa P
    Kidney Blood Press Res; 2012; 35(6):687-93. PubMed ID: 23307115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
    Fabrizi F; Lunghi G; Messa P; Martin P
    J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
    Zheng XY; Wei RB; Tang L; Li P; Zheng XD
    World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
    Wei F; Liu J; Liu F; Hu H; Ren H; Hu P
    PLoS One; 2014; 9(4):e90611. PubMed ID: 24699257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal.
    Fabrizi F; Pozzi C; Farina M; Dattolo P; Lunghi G; Badalamenti S; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1998 Aug; 13(8):1991-7. PubMed ID: 9719153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
    Fabrizi F; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiviral therapy on hepatitis C virus related glomerulopathy.
    Abbas G; Hussain S; Shafi T
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):775-80. PubMed ID: 18711294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
    Zhang Y; Zhou JH; Yin XL; Wang FY
    World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.
    Bruchfeld A; Lindahl K; Ståhle L; Söderberg M; Schvarcz R
    Nephrol Dial Transplant; 2003 Aug; 18(8):1573-80. PubMed ID: 12897097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review.
    Obrișcă B; Jurubiță R; Sorohan B; Iliescu L; Baston C; Bobeică R; Andronesi A; Leca N; Ismail G
    Clin Rheumatol; 2019 Dec; 38(12):3677-3687. PubMed ID: 31172367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.
    Fu B; Ji Y; Hu S; Ren T; Bhuva MS; Li G; Yang H
    PLoS One; 2020; 15(1):e0227532. PubMed ID: 31940324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
    Fabrizi F; Ganeshan SV; Lunghi G; Messa P; Martin P
    J Viral Hepat; 2008 Aug; 15(8):600-6. PubMed ID: 18444984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients.
    Devaki P; Jencks D; Yee BE; Nguyen MH
    Hepatol Int; 2015 Jul; 9(3):431-7. PubMed ID: 26016464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P
    J Med Virol; 2013 Jun; 85(6):1019-27. PubMed ID: 23588727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.
    Cammà C; Giunta M; Andreone P; Craxì A
    J Hepatol; 2001 Apr; 34(4):593-602. PubMed ID: 11394661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.